Novotná J, Miterová L, Krabcová M, Deyl Z, Adam M
Research Institute of Rheumatic Diseases, Czechoslovak Academy of Sciences, Prague, Czechoslovakia.
Z Rheumatol. 1991 Mar-Apr;50(2):99-102.
Au+ binds to the collagen structure and, therefore, the authors studied the kinetics of the interaction between sodium gold thiosulphate (SGTS) and C1q complement subcomponent, the structure of is partially collagenous. The kinetics was evaluated densitometrically and compared with that of collagen and SGTS. On the basis of those results, the effect of SGTS upon collagen type-II-induced arthritis (CIA) was investigated in Wistar rats. SGTS (20 mg per kg of body weight weekly) was administered i.m. starting i) with the first immunization dose, ii) with the second immunization dose, and iii) after the onset of arthritis. Regardless of the timing of drug administration the manifestation of arthritis was decreased, but the decrease was more expressed in the first two groups. It was concluded that SGTS administration is capable of inhibiting CIA, provided that the drug is applied sufficiently early. Since formation of antibodies to type-II collagen remained unaffected, it is feasible that the mode of action of gold complexes is based mainly on blocking the activation of complement system.
金离子(Au+)与胶原蛋白结构结合,因此,作者研究了硫代硫酸金钠(SGTS)与C1q补体亚成分之间相互作用的动力学,C1q补体亚成分的结构部分为胶原质。通过光密度法评估动力学,并与胶原蛋白和SGTS的动力学进行比较。基于这些结果,在Wistar大鼠中研究了SGTS对II型胶原诱导的关节炎(CIA)的影响。SGTS(每周每千克体重20毫克)通过肌肉注射给药,给药时间分别为:i)在首次免疫剂量时;ii)在第二次免疫剂量时;iii)在关节炎发作后。无论给药时间如何,关节炎的表现均有所减轻,但在前两组中减轻更为明显。得出的结论是,只要药物应用足够早,SGTS给药能够抑制CIA。由于针对II型胶原的抗体形成未受影响,金复合物的作用方式主要基于阻断补体系统的激活这一推测是可行的。